Warning: The NCBI web site requires JavaScript to function. more...
Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome.
Raterman HG, Voskuyl AE, Dijkmans BA, Nurmohamed MT.
Arthritis Res Ther. 2009;11(5):413; author reply 414. Epub 2009 Sep 21. No abstract available.
Related citations
Methotrexate treatment and mortality in rheumatoid arthritis.
Rewald E, de las Mercedes Francischetti M.
Lancet. 2002 Oct 5;360(9339):1097. No abstract available.
Slot O.
Lancet. 2002 Oct 5;360(9339):1095; author reply 1097-8. No abstract available.
Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy.
Choi BR, Ahn MJ, Lee WS, Kim TH, Bae SC, Jun JB.
Rheumatol Int. 2005 May;25(4):311-3. Epub 2004 Aug 25.
Tröger U, Bode-Böger SM.
Lancet. 2002 Oct 5;360(9339):1096; author reply 1097-8. No abstract available.
Methotrexate use in rheumatoid arthritis.
O'Dell JR.
Rheum Dis Clin North Am. 1997 Nov;23(4):779-96. Review.
Angio-neurotic oedema associated with methotrexate treatment in rheumatoid arthritis.
Freeman AM, Dasgupta B.
Rheumatology (Oxford). 1999 Sep;38(9):908. No abstract available.
Landewé RB, Breedveld FC, Dijkmans BA.
Lancet. 2002 Oct 5;360(9339):1095-6; author reply 1097-8. No abstract available.
Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis.
Dessein PH, Stanwix AE, Joffe BI.
Arthritis Res. 2002;4(5):R5. Epub 2002 Jun 19.
Is methotrexate oncogenic in patients with rheumatoid arthritis?
Kremer JM.
Semin Arthritis Rheum. 1997 Jun;26(6):785-7. No abstract available.
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Steinberg AD.
N Engl J Med. 1995 Dec 7;333(23):1567; author reply 1568-9. No abstract available.
Schlesinger N, Huppert A, Hoch S.
Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis.
Hamidou MA, Sadr FB, Lamy T, Raffi F, Grolleau JY, Barrier JH.
Am J Med. 2000 Jun 15;108(9):730-2. No abstract available.
Rosh JR, Birnbaum AH.
N Engl J Med. 1995 Dec 7;333(23):1567-8; author reply 1568-9. No abstract available.
Accelerated nodulosis during methotrexate therapy for refractory rheumatoid arthritis. A case report.
Filosa G, Salaffi F, Bugatti L.
Adv Exp Med Biol. 1999;455:521-4.
Storb R, Thomas ED.
N Engl J Med. 1995 Dec 7;333(23):1568; author reply 1568-9. No abstract available.
Pre-treatment X-rays for rheumatoid arthritis treated with methotrexate.
Richards AJ.
Br J Rheumatol. 1997 Nov;36(11):1234-5. No abstract available.
Leukemia of large granular lymphocytes and rheumatoid arthritis.
Starkebaum G.
Am J Med. 2000 Jun 15;108(9):744-5. No abstract available.
Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
Mroczkowski PJ, Weinblatt ME, Kremer JM.
Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S66-8.
"No evidence of disease" in rheumatoid arthritis using methotrexate in combination with other drugs: a contemporary goal for rheumatology care?
Pincus T, Stein CM, Wolfe F.
Clin Exp Rheumatol. 1997 Nov-Dec;15(6):591-6. No abstract available.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on